(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMULAÇÃO DE HEMATOXILINA ESTABILIZADA, MÉTODO PARA CORAR UMA AMOSTRA BIOLÓGICA E KIT

ConcedidaInvention PatentPCT · EP2018061757

Application data

Number

112019021717

Type

Invention Patent

Filing

05/08/2018

Publication

05/12/2020

PCT

EP2018061757

Progress at the INPI

  1. Filing05/08/18
  2. Publication05/12/20
  3. Examination
  4. Allowance01/16/24
  5. Grant03/26/24
  6. In force05/08/38

The patent was granted on 03/26/2024 and is in force until 05/08/2038. Until then, no one may make, use or sell the invention in Brazil without the owner's authorisation.

Protection valid until:05/08/2038

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 03/26/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

VENTANA MEDICAL SYSTEMS, INC.

US

See this company's full portfolio

Inventors

C. K. (pessoa física)

US

E. D. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/504,066 · 05/10/2017

Abstract

A presente invenção fornece formulações estabilizadas de hematoxilina com um pH inferior a 2,4. A presente invenção também fornece métodos de uso de tais formulações estabilizadas de hematoxilina para corar amostras biológicas.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Concessão da patente

#16.1

Prazo de Validade: 20 (vinte) anos contados a partir de 08/05/2018, observadas as condições legais

03/26/2024

RPI 2777

Deferimento

#9.1

01/16/2024

RPI 2767

Parecer de pré-exame

#6.23

08/22/2023

RPI 2746

Adição na publicação

#15.35

10/19/2021

RPI 2650

Notificação de entrada na fase nacional - PCT

#1.3

05/12/2020

RPI 2575

Alteração de dados cadastrais

#1.1

10/29/2019

RPI 2547

Related

Same category

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.